NCT04323839View on ClinicalTrials.gov

COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)

CompletedOBSERVATIONAL
Enrollment

1,333

Participants

Timeline

Start Date

March 20, 2020

Primary Completion Date

April 26, 2022

Study Completion Date

April 26, 2022

Conditions
PregnancyCoronavirusCOVID-19
Interventions
OTHER

Pregnant women under investigation for Coronavirus or diagnosed with COVID-19

This is an observational study with no intervention

OTHER

Postpartum women under investigation for Coronavirus or diagnosed with COVID-19

This is an observational study with no intervention

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

University of California, San Francisco

OTHER

NCT04323839 - COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) | Biotech Hunter | Biotech Hunter